Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Türk · SciRah

Researcher profile · Semantic Scholar

H. Türk

Share profile

H. Türk — researcher profile on SciRah

h-index: 16
Works: 105
Citations: 2,067

Most-cited papers

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
M. Shah, K. Shitara, J. Ajani, Y. Bang +17 more
2023Nature Medicine676 citations Open access
Semantic Scholar
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
A. Sezer, S. Kılıçkap, M. Gümüş, I. Bondarenko +23 more
2021The Lancet591 citations
Semantic Scholar
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Z. Wainberg, P. Enzinger, Yoon-Koo Kang, S. Qin +17 more
2022The Lancet Oncology185 citations
Semantic Scholar
Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).
Z. Wainberg, P. Enzinger, Yoon-Koo Kang, K. Yamaguchi +12 more
202174 citations
Semantic Scholar
Risk factors of nasopharyngeal carcinoma in Turkey-an epidemiological survey of the Anatolian Society of Medical Oncology.
F. Turkoz, G. Celenkoglu, G. Dogu, M. Kalender +5 more
2011Asian Pacific Journal of Cancer Prevention63 citations
Semantic Scholar
FIGHT: A randomized, double-blind, placebo-controlled, phase II study of bemarituzumab (bema) combined with modified FOLFOX6 in 1L FGFR2b+ advanced gastric/gastroesophageal junction adenocarcinoma (GC).
D. Catenacci, Yoon-Koo Kang, A. Saeed, K. Yamaguchi +16 more
202136 citations
Semantic Scholar
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
A. I. Yasin, S. G. Aydin, Bilge Sümbül, L. Koral +25 more
2022Future Oncology31 citations Open access
Semantic Scholar
Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Rui-Hua Xu, K. Shitara, J. Ajani, Y. Bang +16 more
2023Journal of Clinical Oncology29 citations
Semantic Scholar
LBA52 EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%
A. Sezer, S. Kilickap, M. Gümüş, I. Bondarenko +14 more
202026 citations Open access
Semantic Scholar
The risk of malnutrition and its clinical implications in older patients with cancer
Zehra Sucuoğlu İşleyen, M. Beşiroğlu, A. I. Yasin, M. Şimşek +5 more
2023Aging Clinical and Experimental Research23 citations Open access
Semantic Scholar
Paraneoplastic Motor Neuron Disease Resembling Amyotrophic Lateral Sclerosis in a Patient with Renal Cell Carcinoma
H. Türk, A. Ozet, O. Kuzhan, F. Komurcu +3 more
2008Medical Principles and Practice22 citations
Semantic Scholar
Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients
A. Topçu, A. I. Yasin, M. Beşiroğlu, Zehra Sucuoğlu İşleyen +5 more
2024Frontiers in Medicine20 citations Open access
Semantic Scholar
Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study
M. Şimşek, A. Aliyev, T. Baydaş, M. Beşiroğlu +4 more
2022The Breast Journal18 citations Open access
Semantic Scholar
A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer
A. Topçu, A. I. Yasin, Abdallah T M Shbair, M. Beşiroğlu +6 more
2021Journal of Oncology Pharmacy Practice17 citations
Semantic Scholar
Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study
M. Gümüş, Chieh-I Chen, C. Ivanescu, S. Kılıçkap +16 more
2022Cancer16 citations Open access
Semantic Scholar
Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic
A. I. Yasin, A. Topçu, Abdallah T M Shbair, Z. Isleyen +3 more
2021Future Oncology12 citations Open access
Semantic Scholar
Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.
M. A. Gültekin, H. Türk, M. Beşiroğlu, H. Toprak +4 more
2020European Journal of Radiology12 citations
Semantic Scholar
Markers of bone turnover in patients with lung cancer.
F. Dane, H. Türk, A. Sevınc, S. Buyukberber +2 more
2008Journal of the National Medical Association12 citations
Semantic Scholar
Adrenomedullin expression does not correlate with survival in lung cancer
S. Buyukberber, İbrahim Sarı, Celaletdin Camcı, N. Buyukberber +2 more
2007Medical Oncology12 citations
Semantic Scholar
Anastrozole-Associated Sclerosing Glomerulonephritis in a Patient with Breast Cancer
M. Kalender, A. Sevınc, C. Camcı, H. Türk +2 more
2008Oncology11 citations
Semantic Scholar
Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic
Muhammed Yunus Bektay, Z. Şeker, H. Eke, H. Türk +1 more
2022Journal of Oncology Pharmacy Practice10 citations
Semantic Scholar
Apparent Diffusion Coefficient Values for Neuroendocrine Liver Metastases.
M. Gultekin, H. Türk, Ismail Yurtsever, D. Çeşme +3 more
2020Academic Radiology9 citations
Semantic Scholar
A comparison of anticholinergic burden in older patients with and without cancer.
A. I. Yasin, A. Topçu, Meysere Nur Akuç, H. Türk +1 more
2021Future Oncology8 citations
Semantic Scholar
Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer.
H. Türk, C. Camcı, A. Sevınc, Suleyman Bukyukberber +2 more
2012Asian Pacific Journal of Cancer Prevention8 citations Open access
Semantic Scholar
An unusual presentation of extramedullary plasmacytoma in testis and review of the literature
H. Türk, S. Komurcu, A. Ozet, O. Kuzhan +1 more
2010Medical Oncology8 citations
Semantic Scholar
Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks
M. Gultekin, A. Peker, A. B. Oktay, H. Türk +8 more
2023Journal of Clinical Ultrasound7 citations
Semantic Scholar
The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma
A. Topçu, Akın Öztürk, Ismail Yurtsever, M. Beşiroğlu +3 more
2022Bosnian Journal of Basic Medical Sciences7 citations Open access
Semantic Scholar
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥ 50%: EMPOWER-Lung 1 subgroup analysis.
M. Ozguroglu, A. Sezer, S. Kılıçkap, M. Gumus +16 more
20217 citations
Semantic Scholar
Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients
M. Seker, H. C. Isen, N. Çevirme, S. Aydın +8 more
2018Oncology Research and Treatment7 citations
Semantic Scholar
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma.
S. Alıcı, S. Buyukberber, N. Alkış, M. Benekli +9 more
2013Asian Pacific Journal of Cancer Prevention7 citations Open access
Semantic Scholar
Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.
M. Beşiroğlu, Abdallah T M Shbair, A. I. Yasin, A. Topçu +2 more
2021Journal of the College of Physicians and Surgeons--Pakistan : JCPSP6 citations Open access
Semantic Scholar
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?
T. Demir, A. Aliyev, M. Beşiroğlu, Murat Araz +7 more
2020Current Problems in Cancer6 citations
Semantic Scholar
Factors affecting engraftment time in autologous peripheral stem cell transplantation.
H. Türk, S. Komurcu, F. Arpacı, A. Ozet +6 more
2010Asian Pacific Journal of Cancer Prevention6 citations
Semantic Scholar
Local interventions for colorectal cancer metastases to liver and lung
M. Şimşek, M. Beşiroğlu, A. Akçakaya, A. Topçu +4 more
2023Irish Journal of Medical Science5 citations
Semantic Scholar
OA01.03 Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC
S. Kılıçkap, A. Sezer, M. Gumus, I. Bondarenko +20 more
20214 citations
Semantic Scholar
Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.
H. Türk, A. Aliyev, Rabia Çeli̇k, M. Seker +4 more
2020Current Problems in Cancer4 citations
Semantic Scholar
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
A. Alkan, A. Yaşar, Z. Güç, Mustafa Gürbüz +26 more
2020European Journal of Cancer Care4 citations Open access
Semantic Scholar
Akciğer, meme ve kolon kanserli hastalarda oksidatif stres parametrelerinin değişimi
Ö. Özer, E. Güler, Şahabettin Selek, Ganime Çoban +2 more
2019Harran üniversitesi tıp fakültesi dergisi4 citations Open access
Semantic Scholar
Opinions of the Turkish population on cancer and being informed of the diagnosis of cancer.
A. Yalçın, K. Sılay, A. Büyükçelik, A. Işıkdoğan +6 more
2015Turkish Journal of Medical Sciences4 citations Open access
Semantic Scholar
Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram
A. I. Yasin, Mahmut Uluganyan, Z. Isleyen, A. Topçu +6 more
2024Supportive Care in Cancer3 citations Open access
Semantic Scholar
Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and high (>50%) programmed cell death-ligand 1 (PD-L1) expression, randomized to cemiplimab (cemi) vs chemotherapy (chemo).
N. Vokes, D. Gandara, A. Sezer, S. Kılıçkap +16 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
S. Esen, Y. Ergun, C. Erol, R. Arıkan +30 more
2022Bosnian Journal of Basic Medical Sciences3 citations Open access
Semantic Scholar
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.
A. Topçu, M. Atcı, Şaban Seçmeler, M. Beşiroğlu +8 more
2021Future Oncology3 citations
Semantic Scholar
Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 ≥ 50%: Results from EMPOWER-Lung 1 study.
M. Gumus, Chieh-I Chen, C. Ivanescu, S. Kılıçkap +16 more
20213 citations
Semantic Scholar
Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Neoplasms.
Abdusselam Sekerci, H. Türk, T. Demir, M. Seker +2 more
2020Journal of the College of Physicians and Surgeons--Pakistan : JCPSP3 citations Open access
Semantic Scholar
Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on 18F-FDG PET/CT
E. Erdoğan, H. Türk, Ertuğrul Tekçe, M. Aydın
2018Molecular Imaging and Radionuclide Therapy3 citations Open access
Semantic Scholar
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors
Zehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu, M. Beşiroğlu +5 more
2025Medicina2 citations Open access
Semantic Scholar
Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis.
NO Kalkan, G. Ucar, S. Esen, M. Bardakçı +22 more
2025Nigerian Journal of Clinical Practice2 citations Open access
Semantic Scholar
Evaluation of Toxic Effects of Chemotherapy in Lung Malignancies on Cerebral White Matter Using Diffusion Tensor Imaging
S. Aydın, T. Demir, H. Türk, D. Çeşme +4 more
2022Radiology and Oncology2 citations Open access
Semantic Scholar
Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer
S. Bilgin, M. Gultekin, Ismail Yurtsever, T. F. Yılmaz +7 more
2021Magnetic Resonance in Medical Sciences2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Beşiroğlu×15
Invite
M. Beşiroğlu — researcher profile on SciRah
A. I. Yasin×14
Invite
A. I. Yasin — researcher profile on SciRah
M. Seker×14
Invite
M. Seker — researcher profile on SciRah
A. Topçu×13
Invite
A. Topçu — researcher profile on SciRah

×7

Invite

M. Gogishvili — researcher profile on SciRah

Invite

I. Çiçin — researcher profile on SciRah

Invite

G. Gullo — researcher profile on SciRah

Invite

M. Şimşek — researcher profile on SciRah

Invite

T. Demir — researcher profile on SciRah

Abdallah T M Shbair×7

Invite

Abdallah T M Shbair — researcher profile on SciRah

Invite

A. Sezer — researcher profile on SciRah

S. Kılıçkap×6

Invite

S. Kılıçkap — researcher profile on SciRah